Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
As an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, retatrutide is not currently approved in the UK and remains available only within authorised clinical trials
This signals a major shift in the countrys diabetes and obesity care market
These pens allow patients to continue peptide therapy at home with confidence and ease
[[1], [2], [6], [7]] The three approved injection sites Mounjaro can be injected into three areas: the abdomen, the front of the thigh, or the back of the upper arm
US$ 21.19
US$ 27.65
US$ 22.58
US$ 26.59
